宣肺通腑法在重症肺炎集束化治疗中的临床观察

发布时间：2018-08-29 16:31

【摘要】：目的:观察宣肺通腑法在重症肺炎集束化治疗中的临床疗效,探讨其在重症肺炎治疗中的临床价值。方法:将62例重症肺炎患者随机分为对照组(n=30)和治疗组(n=32)。对照组给予氧疗、抗感染、营养支持及维持内环境稳定等集束化治疗;治疗组在集束化治疗基础上加用晁老通腑方汤剂口服,每天1剂,共5 d。比较两组患者在治疗前及治疗后第3、5天血C-反应蛋白、降钙素原、血气分析的变化,机械通气时间及住ICU时间、因为重症肺炎导致的死亡率,并进行统计学分析。结果:两组患者在治疗后第3、5天血C-反应蛋白、降钙素原、血气分析等方面比较差异均有统计学意义(P0.05);两组机械通气时间、住ICU时间及死亡率比较,治疗组预后更佳(P0.05)。结论:宣肺通腑法在重症肺炎集束化治疗中能有效改善氧合,协助抗炎、抗感染作用,减少机械通气时间及留住ICU时间,可以有效提高重症肺炎的治疗效果。
[Abstract]:Objective: to observe the clinical effect of Xuanfei Tongfu method in the cluster therapy of severe pneumonia and to explore its clinical value in the treatment of severe pneumonia. Methods: 62 patients with severe pneumonia were randomly divided into control group (n = 30) and treatment group (n = 32). The control group was treated with oxygen therapy, anti-infection, nutritional support and maintenance of stable internal environment, while the treatment group was treated with Chao Lao Tong Fu decoction orally, 1 dose per day for 5 days. The changes of serum C-reactive protein, procalcitonin, blood gas analysis, mechanical ventilation time and ICU duration were compared between the two groups before and after treatment on the 5th day after treatment, and the mortality caused by severe pneumonia was analyzed statistically. Results: there were significant differences in serum C-reactive protein, procalcitonin and blood gas analysis between the two groups on the 3rd day after treatment (P0.05), and the time of mechanical ventilation, the duration of ICU residence and the mortality of the two groups were better than those in the treatment group (P0.05). Conclusion: Xuanfei Tongfu method can effectively improve oxygenation, assist anti-inflammatory and anti-infective effects, reduce mechanical ventilation time and retain ICU time in the treatment of severe pneumonia, and can effectively improve the therapeutic effect of severe pneumonia.
【作者单位】：广东省中医院;
【基金】：广东省自然科学基金(编号:2016A030313636) 广东省中医院晁思祥名中医药专家传承工作室
【分类号】：R563.1

【相似文献】